Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.96% is 74% above its 5-year average of 4.58%, near the high end of its 5-year range (0.00%–7.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 53.89% above its 12-month average of 5.17%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.96%.
DEBT TO ASSETS RATIO
7.96%
DEBT TO ASSETS RATIO AVG TTM
5.17%
DEBT TO ASSETS RATIO AVG 3Y
4.40%
DEBT TO ASSETS RATIO AVG 5Y
4.58%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+53.89%
CURRENT VS 3Y AVG
+81.04%
CURRENT VS 5Y AVG
+73.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 575 covered companies
CURRENT VS SECTOR MEDIAN
+7860.98%
vs the sector median at left
4D Molecular Therapeutics, Inc.
Market Cap
$646.50M
Debt to Assets Ratio
7.96%
TTM Avg
5.17%
3Y Avg
4.40%
5Y Avg
4.58%
Market Cap
$635.14M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$666.85M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$621.12M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$620.81M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$683.14M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | $646.50M | 7.96% | 5.17% | 4.40% | 4.58% |
| Helus Pharma Inc. (HELP)vs › | $658.52M | 0.00% | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $635.14M | 0.05% | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $666.85M | 0.01% | N/A | N/A | N/A |
| Annexon, Inc. (ANNX)vs › | $667.66M | 0.10% | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $623.31M | 0.01% | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $621.12M | 0.01% | N/A | N/A | N/A |
| AngioDynamics, Inc. (ANGO)vs › | $620.81M | 0.00% | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $683.14M | 0.00% | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $598.37M | 1.39% | N/A | N/A | N/A |
Debt/Assets
8.0%
Debt/Equity
0.10
Current Ratio
8.03
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 7.96% |
| 2026-03-31 | 4.00% |
| 2025-12-31 | 3.78% |
| 2025-09-30 | 5.25% |
| 2025-06-30 | 4.87% |
| 2025-03-31 | 4.63% |
| 2024-12-31 | 4.39% |
| 2024-09-30 | 4.11% |
| 2024-06-30 | 2.20% |
| 2024-03-31 | 2.25% |
| 2023-12-31 | 4.32% |
| 2023-09-30 | 4.19% |
| 2023-06-30 | 4.43% |
| 2023-03-31 | 6.43% |
| 2022-12-31 | 6.16% |
| 2022-09-30 | 5.91% |
| 2022-06-30 | 5.61% |
| 2022-03-31 | 5.18% |
| 2021-12-31 | 4.65% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
